Formulation

Nov 30, 2015
By BioPharm International Editors
Paras Biopharmaceuticals and Novozymes will collaborate on the creation of an improved osteoporosis treatment.
Nov 19, 2015
By BioPharm International Editors
Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.
Nov 19, 2015
By BioPharm International Editors
Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.
Nov 13, 2015
BioPharm International
By BioPharm International Editors
A new consortium involving Arecor, Fujifilm Diosynth Biotechnologies, and the UK's Center for Process Innovation will focus on formulation innovation as a way to improve downstream processing and reduce biopharmaceutical cost.
Oct 14, 2015
By BioPharm International Editors
The company presented a portfolio of new products during the meeting in Madrid.
Oct 02, 2015
BioPharm International
This article introduces the technology that powers automated HT–DLS and explores its practical applications in enhancing formulation stability investigations.
Sep 29, 2015
By BioPharm International Editors
The project seeks to index the properties of various proteins in solution and create a home for data on the performance of product excipients with their active substances.
Sep 28, 2015
By BioPharm International Editors
Although the Committee for Medicinal Products for Human Use (CHMP) gave Blincyto a positive opinion, full approval of the drug in the EMA will rely on additional clinical studies.
Sep 16, 2015
Under terms of the agreement, Amgen will license Xencor’s XmAb technology platform for five Amgen programs and one Xencor program.
native1_300x100
lorem ipsum